Robert C. Holman

Robert C. Holman

Auto-generated profile, based on publicly available information

Robert C. Holman

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (USDHHS), Atlanta, GA 30333, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RHRobert C. Holman
Robert C. Holman
EBErmias D. Belay
Ermias D. Belay
KCKrista Y. Christensen
Krista Y. Christensen
AFArianne M. Folkema
Arianne M. Folkema
CSClaudia A. Steiner
Claudia A. Steiner
LSLawrence B. Schonberger
Lawrence B. Schonberger
The present study describes the rate and trends of childhood hospitalizations with Kawasaki syndrome (KS) in the United States. Retrospective analysis of hospitalizations with KS among children <18 years of age in the United States using the Kids' Inpatient Database (1997, 2000, 2003, and 2006) and the Nationwide Inpatient Sample (1998-2007). The KS-associated hospitalization rate for children <5 years of age was 20.8 (95% CI: 18.5-23.1) per 100,000 children in 2006. Annual rates remained constant during the study period, except for a peak in 2005. In 2006, 76.8% (SE = 0.9%) of an estimated 5523 (SE = 289) KS-associated hospitalizations among children <18 years of age were <5 years of age. The mean age for all children at hospitalization was 3.0 years (SE <0.1); 25.7 months (SE = 0.3) for children <5 years of age, and 24.8 months (SE = 0.4) and 27.1 months (SE = 0.5) for boys and girls, respectively. The rate for boys was higher than that for girls (24.2 [95% CI: 21.3-27.1] and 16.8 [95% CI: 14.7-18.9], respectively). The rate for Asian/Pacific Islander children (30.3 [95% CI: 20.2-40.4]) was the highest among the racial groups. The national KS-associated annual hospitalization rate for children <5 years of age from 1997 to 2007 was relatively stable and was similar to previously published rates, except for an increase in 2005. Most hospitalizations were in children <3 years of age with few hospitalizations during the first 2 months of age. Children of Asian/Pacific Islander descent had the highest hospitalization rate.

1 January 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RHRobert C. Holman
Robert C. Holman
EBErmias D. Belay
Ermias D. Belay
KCKrista Y. Christensen
Krista Y. Christensen
RMRyan A. Maddox
Ryan A. Maddox
AMArialdi M. Minino
Arialdi M. Minino
LSLawrence B. Schonberger
Lawrence B. Schonberger
Prion diseases are a family of rare, progressive, neurodegenerative disorders that affect humans and animals. The most common form of human prion disease, Creutzfeldt-Jakob disease (CJD), occurs worldwide. Variant CJD (vCJD), a recently emerged human prion disease, is a zoonotic foodborne disorder that occurs almost exclusively in countries with outbreaks of bovine spongiform encephalopathy. This study describes the occurrence and epidemiology of CJD and vCJD in the United States. Analysis of CJD and vCJD deaths using death certificates of US residents for 1979–2006, and those identified through other surveillance mechanisms during 1996–2008. Since CJD is invariably fatal and illness duration is usually less than one year, the CJD incidence is estimated as the death rate. During 1979 through 2006, an estimated 6,917 deaths with CJD as a cause of death were reported in the United States, an annual average of approximately 247 deaths (range 172–304 deaths). The average annual age-adjusted incidence for CJD was 0.97 per 1,000,000 persons. Most (61.8%) of the CJD deaths occurred among persons ≥65 years of age for an average annual incidence of 4.8 per 1,000,000 persons in this population. Most deaths were among whites (94.6%); the age-adjusted incidence for whites was 2.7 times higher than that for blacks (1.04 and 0.40, respectively). Three patients who died since 2004 were reported with vCJD; epidemiologic evidence indicated that their infection was acquired outside of the United States. Surveillance continues to show an annual CJD incidence rate of about 1 case per 1,000,000 persons and marked differences in CJD rates by age and race in the United States. Ongoing surveillance remains important for monitoring the stability of the CJD incidence rates, and detecting occurrences of vCJD and possibly other novel prion diseases in the United States.

1 August 2010
Verified
Journal Article
Closed access
RHRobert C Holman
Robert C Holman
KCKrista Y Christensen
Krista Y Christensen
EBErmias D Belay
Ermias D Belay
CSClaudia A Steiner
Claudia A Steiner
PEPaul V Effler
Paul V Effler
MMMarian Melish
Marian Melish

1 July 2011 in Public Health Reports®
Verified
Journal Article
Closed access
RHRobert C. Holman
Robert C. Holman
AFArianne M. Folkema
Arianne M. Folkema
RSRosalyn J. Singleton
Rosalyn J. Singleton
JRJohn T. Redd
John T. Redd
KCKrista Y. Christensen
Krista Y. Christensen
JCJames E. Cheek
James E. Cheek
Objectives.: We described disparities in infectious disease (ID) hospitalizations for American Indian/Alaska Native (AI/AN) people. Methods.: We analyzed hospitalizations with an ID listed as the first discharge diagnosis in 1998–2006 for AI/AN people from the Indian Health Service National Patient Information Reporting System and compared them with records for the general U.S. population from the Nationwide Inpatient Survey. Results.: The ID hospitalization rate for AI/AN people declined during the study period. The 2004–2006 mean annual age-adjusted ID hospitalization rate for AI/AN people (1,708 per 100,000 populiation) was slightly higher than that for the U.S. population (1,610 per 100,000 population). The rate for AI/AN people was highest in the Southwest (2,314 per 100,000 population), Alaska (2,063 per 100,000 population), and Northern Plains West (1,957 per 100,000 population) regions, and among infants (9,315 per 100,000 population). ID hospitalizations accounted for approximately 22% of all AI/AN hospitalizations. Lower-respiratory-tract infections accounted for the largest proportion of ID hospitalizations among AI/AN people (35%) followed by skin and soft tissue infections (19%), and infections of the kidney, urinary tract, and bladder (11%). Conclusions.: Although the ID hospitalization rate for AI/AN people has declined, it remains higher than that for the U.S. general population, and is highest in the Southwest, Northern Plains West, and Alaska regions. Lower-respiratory-tract infections; skin and soft tissue infections; and kidney, urinary tract, and bladder infections contributed most to these health disparities. Future prevention strategies should focus on high-risk regions and age groups, along with illnesses contributing to health disparities.

1 July 2012 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
JMJason M. Mehal
Jason M. Mehal
DEDouglas H. Esposito
Douglas H. Esposito
RHRobert C. Holman
Robert C. Holman
JTJacqueline Tate
Jacqueline Tate
LCLaura S. Callinan
Laura S. Callinan
UPUmesh D. Mb Bs Parashar
Umesh D. Mb Bs Parashar
Background: Diarrhea-associated deaths among US children increased from the mid-1980s through 2006, particularly among infants. Understanding risk factors for diarrhea-associated death could improve prevention strategies. Methods: Records of singleton infants with diarrhea listed anywhere on the death certificate were selected from the US Linked Birth/Infant Death data for the period, 2005 to 2007; characteristics of these infants were compared with those of infants who survived their first year. Results: During 2005 to 2007, 1087 diarrhea-associated infant deaths were reported; 86% occurred among low birth weight (LBW, <2500 g) infants. Compared with normal birth weight (NBW, ≥2500 g) infants, LBW infants had a greater mortality rate (risk ratio: 91.9, 95% confidence interval: 77.4–109.0) and younger median age at death (7 versus 15 weeks, P < 0.0001). The most common codiagnoses for diarrhea-associated death among LBW and NBW infants were sepsis (26%) and volume depletion (20%), respectively. Among LBW infants, 97% of diarrhea-associated deaths occurred in inpatient settings, whereas 27% of NBW infant deaths occurred in outpatient settings and 5.3% in the decedent’s home. Male sex, black race, unmarried status and low 5-minute Apgar score (<7) increased mortality odds among LBW infants whereas, among NBW infants, low 5-minute Apgar score, black race, young maternal age (<25 years) and high birth order (third or more) increased mortality odds. Conclusions: Efforts to reduce diarrhea-associated morality should focus on understanding and improving management of diarrhea in vulnerable LBW infants. For prevention of diarrhea-associated deaths in NBW infants, educating mothers who fit the high-risk profile regarding home hydration therapy and timely access to medical treatment is important.

31 January 2013 in International Journal of Circumpolar Health
Verified
Journal Article
Open access
PDF file
RHRobert C. Holman
Robert C. Holman
THThomas W. Hennessy
Thomas W. Hennessy
DHDana L. Haberling
Dana L. Haberling
LCLaura S. Callinan
Laura S. Callinan
RSRosalyn J. Singleton
Rosalyn J. Singleton
MBMichael G. Bruce
Michael G. Bruce
Increasing trend in the rate of infectious disease hospitalisations among Alaska Native people